Table 1. Correlation between preoperative ANRI and clinicopathologic characteristics in HCC.
| Variables | Cases | ANRI | Χ2 | r | P value | |
|---|---|---|---|---|---|---|
| ≤ 7.8 | > 7.8 | |||||
| Age(yrs) | ||||||
| ≥ 60 | 73 | 24(32.9%) | 49(67.1%) | 0.287 | 0.592 | |
| < 60 | 230 | 68(29.6%) | 162(70.4%) | |||
| Gender | ||||||
| Male | 271 | 80(29.5%) | 191(70.5%) | 0.862 | 0.353 | |
| Female | 32 | 12(37.5%) | 20(62.5%) | |||
| HCC family history | ||||||
| Yes | 21 | 9(42.9%) | 12(57.1%) | 1.666 | 0.197 | |
| No | 282 | 83(29.4%) | 199(70.6%) | |||
| HBsAg | ||||||
| Positive | 266 | 73(27.4%) | 193(72.6%) | 8.781 | 0.170 | 0.003 |
| Negative | 37 | 19(51.4%) | 18(48.6%) | |||
| AST(U/L) | ||||||
| < 80 | 249 | 92(36.9%) | 157(63.1%) | 28.651 | 0.308 | <0.001 |
| ≥ 80 | 54 | 0(0%) | 54(100%) | |||
| TBIL(μmol/L) | ||||||
| < 34.2 | 277 | 88(31.8%) | 189(68.2%) | 3.018 | 0.082 | |
| ≥ 34.2 | 26 | 4(15.4%) | 22(84.6%) | |||
| PLT(×109) | ||||||
| ≥ 100 | 275 | 87(31.6%) | 188(68.4%) | 2.282 | 0.131 | |
| < 100 | 28 | 5(17.9%) | 23(82.1%) | |||
| Cirrhosis | ||||||
| Yes | 237 | 61(25.7%) | 176(74.3%) | 11.006 | 0.191 | 0.001 |
| No | 66 | 31(47.0%) | 35(53.0%) | |||
| AFP(μg/L) | ||||||
| ≥ 200 | 171 | 48(28.1%) | 123(71.9%) | 0.976 | 0.323 | |
| < 200 | 132 | 44(33.3%) | 88(66.7%) | |||
| Tumor size(cm) | ||||||
| > 5 | 198 | 51(25.8%) | 147(74.2%) | 5.732 | 0.156 | 0.017 |
| ≤ 5 | 105 | 41(39.0%) | 64(61.0%) | |||
| Tumor number | ||||||
| Single | 215 | 71(33.0%) | 144(67.0%) | 2.478 | 0.115 | |
| Multiple | 88 | 21(23.9%) | 67(76.1%) | |||
| TNM | ||||||
| I | 175 | 59(33.7%) | 116(66.3%) | 2.200 | 0.138 | |
| II-III | 128 | 33(25.8%) | 95(74.2%) | |||
| Differentiation | ||||||
| I-II | 235 | 75(31.9%) | 160(68.1%) | 1.193 | 0.275 | |
| III-IV | 68 | 17(25.0%) | 51(75.0%) | |||
| PVTT | ||||||
| Yes | 53 | 10(18.9%) | 43(81.1%) | 4.014 | 0.115 | 0.045 |
| No | 250 | 82(32.8%) | 168(67.2%) | |||
| CLIP score | ||||||
| 0-2 | 217 | 78(35.9%) | 139(64.1%) | 11.265 | 0.193 | 0.001 |
| 3-5 | 86 | 14(16.3%) | 72(83.7%) | |||
| Recurrence | ||||||
| Yes | 222 | 52 (23.4%) | 170(76.6%) | 18.915 | 0.250 | <0.001 |
| No | 81 | 40(49.4%) | 41(50.6%) | |||
| Complication | ||||||
| No | 258 | 82(31.8%) | 176(68.2%) | 1.656 | 0.198 | |
| Yes | 45 | 10(22.2%) | 35(77.8%) | |||
HBsAg: hepatitis B surface antigen; AST: aspartate aminotransferase ratio index; TBIL: total bilirubin; PLT: platelet; AFP:alpha-fetoprotein; TNM: Tumor Node Metastasis; PVTT: portal vein tumor thrombus; CLIP: cancer of the liver Italian program; ANRI, Aspartate aminotransferase/neutrophil count ratio index.